Resurrect Bio expands Series A to $10.3m to scale tech helping plants to defend themselves

UK-based startup Resurrect Bio has successfully expanded its Series A funding to $10.3 million, aimed at enhancing its technology that helps crops develop genetic defenses against diseases. The round was led by Corteva and includes participation from several investors, bringing the company's total funding to $12.4 million. The new capital will be used to grow the team and further develop disease resistance traits in key agricultural crops.